A matter of inflammation: CAR T-cell therapy and atrial fibrillation

被引：0

作者：

Chen, S. ^{[1
]}

Gonzalez, H. ^{[1
]}

Ghorbanzadeh, A. ^{[1
]}

Korleski, J. ^{[1
]}

Donisan, T. ^{[1
]}

Lewis, B. ^{[1
]}

Lin, Y. ^{[1
]}

Herrmann, J. ^{[1
]}

机构：

[1] Mayo Clin, Rochester, MN USA

来源：

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：2

共 50 条

[21] Filgrastim associations with CAR T-cell therapy
Gaut, Daria
Tang, Kevin
Sim, Myung Shin
Tuyen Duong
Young, Patricia
Sasine, Joshua
INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (05) : 1192 - 1196
[22] CAR T-cell therapy for multiple myeloma
Zhou, X.
Einsele, H.
Danhof, S.
INTERNIST, 2021, 62 (06): : 605 - 610
[23] CAR T-Cell Therapy: Progress and Prospects
Wilkins, Olivia
Keeler, Allison M.
Flotte, Terence R.
HUMAN GENE THERAPY METHODS, 2017, 28 (02) : 61 - 66
[24] Managing the toxicities of CAR T-cell therapy
Neelapu, Sattva S.
HEMATOLOGICAL ONCOLOGY, 2019, 37 : 48 - 52
[25] Hematopathologic Correlates of CAR T-Cell Therapy
Dolan, J. Gregory
Paessler, Michele E.
Rheingold, Susan R.
Pillai, Vinodh
CLINICS IN LABORATORY MEDICINE, 2021, 41 (03) : 325 - 339
[26] CAR T-cell therapy: opportunities and challenges
Zhang, Wenlong
IMMUNOTHERAPY, 2016, 8 (03) : 245 - 247
[27] CAR T-cell therapy in autoimmune diseases
Schett, Georg
Mackensen, Andreas
Mougiakakos, Dimitrios
LANCET, 2023, 402 (10416): : 2034 - 2044
[28] CAR T-Cell Therapy for Ovarian Cancer
Yeku, Oladapo
ONCOLOGIST, 2018, 23 : S3 - S3
[29] Cardiovascular Toxicities of CAR T-cell Therapy
Patel, Nikita P.
Doukas, Peter G.
Gordon, Leo, I
Akhter, Nausheen
CURRENT ONCOLOGY REPORTS, 2021, 23 (07)
[30] CAR T-cell therapy for pancreatic cancer
DeSelm, Carl J.
Tano, Zachary E.
Varghese, Anna M.
Adusumilli, Prasad S.
JOURNAL OF SURGICAL ONCOLOGY, 2017, 116 (01) : 63 - 74